An Open Label Extension Study of Ublituximab in Subjects With Relapsing Multiple Sclerosis
Condition: Relapsing Multiple Sclerosis (RMS) Intervention: Biological: Ublituximab Sponsor: TG Therapeutics, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials